VIAL
Compound comparison

Anastrozole vs Estradiol

Anastrozole and Estradiol are both hormone compounds evaluated on Vial: Anastrozole is FDA approved with FDA-approval-level clinical evidence, and Estradiol is FDA approved with clinical-trial evidence, offered by 13 and 8 verified providers respectively.

Vial summary · compiled from public records

At a glance

Anastrozole

Sold as Arimidex

Category
Hormone
FDA / legal status
FDA Approved
Route
Oral
13providers on Vial →

Estradiol

Sold as Estrace, Climara

Category
Hormone
FDA / legal status
FDA Approved
Route
Oral, transdermal, injectable
8providers on Vial →

Side by side

FieldAnastrozoleEstradiol
CategoryHormoneHormone
Brand namesArimidexEstrace, Climara
FDA / legal statusFDA ApprovedFDA Approved
Evidence tierFDA ApprovedClinical Trials
Administration routeOralOral, transdermal, injectable
Compounding accessFDA-approved product, dispensed by prescriptionFDA-approved product, dispensed by prescription
Providers on Vial13 listed8 listed
Typical price band$$ to $$$$$

Verified providers offering each

Ranked by Confidence Rating, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.

85+ High Confidence70 to 84 Well Documented50 to 69 Limited ConfidenceUnder 50 Flagged

About each compound

About Anastrozole

Anastrozole is an FDA-approved aromatase inhibitor used in TRT protocols to manage estradiol levels that become elevated during testosterone therapy. By blocking aromatase enzyme activity, it prevents excess conversion of testosterone to estradiol, mitigating estrogenic side effects such as gynecomastia and water retention. It is one of the most commonly prescribed ancillary medications in men's health and hormone optimization.

About Estradiol

Estradiol is the primary biologically active estrogen and is the cornerstone of female hormone replacement therapy for menopause management. It protects against cardiovascular disease, osteoporosis, cognitive decline, and urogenital atrophy. Transdermal delivery avoids first-pass metabolism and provides more stable levels than oral estrogen. It is used in optimization medicine to maintain youthful estradiol levels in perimenopausal and postmenopausal women.

Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.

Related compound comparisons

Other comparisons in the same category.

All compound comparisons →